KRYSTAL BIOTECH INC

Ticker: KRYS CUSIP: 501147102 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 25,000 Value ($000) $6,164 Avg Close $210.47 Range $175.85 - $265.92

Q3 2025

Shares 11,750 Value ($000) $2,074 Avg Close $149.68 Range $130.50 - $178.20

Q2 2025

Shares 12,750 Value ($000) $1,753 Avg Close $146.88 Range $122.80 - $182.16

Q1 2025

Shares 17,750 Value ($000) $3,200 Avg Close $168.21 Range $141.72 - $197.94

Q4 2024

Shares 23,750 Value ($000) $3,721 Avg Close $177.39 Range $154.16 - $207.84

Q3 2024

Shares 17,000 Value ($000) $3,095 Avg Close $192.81 Range $164.81 - $219.34

Q2 2024

Shares 19,000 Value ($000) $3,489 Avg Close $167.89 Range $144.00 - $191.78

Q1 2024

Shares 19,000 Value ($000) $3,381 Avg Close $138.91 Range $107.50 - $189.97

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	25,000	$6,164	$210.47	$175.85 - $265.92
Q3 2025	11,750	$2,074	$149.68	$130.50 - $178.20
Q2 2025	12,750	$1,753	$146.88	$122.80 - $182.16
Q1 2025	17,750	$3,200	$168.21	$141.72 - $197.94
Q4 2024	23,750	$3,721	$177.39	$154.16 - $207.84
Q3 2024	17,000	$3,095	$192.81	$164.81 - $219.34
Q2 2024	19,000	$3,489	$167.89	$144.00 - $191.78
Q1 2024	19,000	$3,381	$138.91	$107.50 - $189.97